Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Restructuring-related asset impairments by Year
Restructuring-related asset impairments ($M) ($M)
Pfizer Restructuring-related asset impairments: $349M in FY2025, down 19.2% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-Q / 10-K Note 3 — Restructuring Charges & Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Restructuring-related asset impairments ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 349 | -19.2% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 432 | +90.3% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 227 | +336.5% | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 52 | -1.9% | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 53 | -19.7% | Form 10-K (filed 2024-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 66 | -4.3% | Form 10-K (filed 2023-02-23) ↗ |
| FY2019 | Dec 31, 2019 | 69 | -76.2% | Form 10-K (filed 2022-02-24) ↗ |
| FY2018 | Dec 31, 2018 | 290 | +52.6% | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 190 | +33.8% | Form 10-K (filed 2020-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 142 | -44.1% | Form 10-K (filed 2019-02-28) ↗ |
| FY2015 | Dec 31, 2015 | 254 | – | Form 10-K (filed 2018-02-22) ↗ |
Cite this data
StockData. (2026). Pfizer Restructuring-related asset impairments ($M), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/restruct-chg-imp
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.